Apigenin
Apigenin (4′,5,7-trihydroxyflavone) is a flavone found in various food and medicinal plants. In human biology, it is being researched for modulation of inflammation, oxidative stress, metabolism, and cellular signaling associated with aging. The strongest evidence comes from in vitro studies and animal models; clinical data in humans are still limited and often heterogeneous.
A flavonoid phytocompound studied for anti-inflammatory, antioxidant, and potential pro-longevity pathways (predominantly preclinical evidence).
Apigenin (4′,5,7-trihydroxyflavone) is a flavone found in various food and medicinal plants. In human biology, it is the subject of research for its modulation of inflammation, oxidative stress, metabolism, and cellular signaling associated with aging. The strongest evidence comes from in vitro studies and animal models; clinical data in humans are still limited and often heterogeneous.
Mechanism of action
Proposed mechanisms (dependent on dose, context, and experimental model): modulation of NF-κB and reduction of the expression of pro-inflammatory mediators (e.g. COX-2, iNOS, cytokines); direct and indirect antioxidant activity with possible activation of Nrf2/ARE and increased phase II enzymes; interaction with MAPK pathways (ERK/JNK/p38) and PI3K/Akt; effects on mitochondrial homeostasis and mitochondrial biogenesis/quality in preclinical models; modulation of autophagy and cellular senescence in some models (evidence inconclusive); potential activity in inhibiting specific kinases and modulation of the cell cycle (relevant mainly in preclinical oncology); interactions with receptors and transporters (e.g. GABA-A in neurobiological contexts; inhibition of some enzymes/transporters involved in drug metabolism in vitro).
Supported benefits
- Reduction of inflammatory markers and oxidative stress (mainly in preclinical models; in humans, data are limited and inconsistent). (moderate)
- Support for metabolic health parameters (blood glucose, lipids, insulin sensitivity) in animal models; clinical evidence is still limited and not specific to isolated apigenin. (limited)
- Neuroprotection and modulation of anxiety/sleep in preclinical models; in humans, evidence is indirect and often linked to plant matrices (e.g. chamomile) rather than pure apigenin. (limited)
- Chemopreventive/anti-proliferative activity in vitro and in vivo (preclinical oncology); not demonstrated as a clinical benefit in prevention or treatment in humans. (emerging)
- Possible modulation of pathways associated with cellular longevity (autophagy/senescence/mitochondria) in experimental models; clinical longevity endpoints are lacking. (emerging)
Safety & side effects
- Gastrointestinal disturbances (nausea, dyspepsia, diarrhea) occasionally reported with high-dose polyphenols.
- Drowsiness or sedation in sensitive individuals (plausible due to neurobiological interactions; more often associated with chamomile/extracts).
- Headache or dizziness (uncommon, non-specific reports).
- Allergic reactions: possible especially in individuals allergic to plants of the Asteraceae family (e.g. chamomile), if exposure occurs through plant extracts.
FAQ
Is apigenin a “senolytic”?
Some preclinical studies suggest that it may influence cellular senescence and related pathways, but there is no solid clinical evidence demonstrating a senolytic effect in humans or benefits on longevity endpoints.
Is it better to take it from foods or as a supplement?
From a safety standpoint, intake through foods and traditional infusions has the longest history of use. Supplements may provide higher and standardized doses, but they increase uncertainty regarding bioavailability, interactions, and long-term safety.
Does apigenin cross the blood-brain barrier?
In experimental models, some flavones can reach the CNS, often as metabolites; the quantitative relevance in humans and the association with clinical effects remain unclear.
Can it improve sleep?
The best-known evidence concerns chamomile and plant preparations, where the effect may depend on multiple components. For isolated apigenin, clinical data are limited and do not allow robust conclusions.
Which biomarkers would make sense to monitor in human studies?
In research contexts: hs-CRP and inflammatory cytokines, markers of oxidative stress, lipid and glycemic profile, endothelial function parameters; however, there are no validated biomarkers demonstrating a direct effect on human longevity.
The information provided is for informational and educational purposes only. It does not constitute medical advice. Use must be evaluated and authorized by a qualified healthcare professional.
Mechanism of action
Proposed mechanisms (depending on dose, context, and experimental model): modulation of NF-κB and reduction of the expression of pro-inflammatory mediators (e.g., COX-2, iNOS, cytokines); direct and indirect antioxidant activity with possible activation of Nrf2/ARE and increase in phase II enzymes; interaction with MAPK pathways (ERK/JNK/p38) and PI3K/Akt; effects on mitochondrial homeostasis and mitochondrial biogenesis/quality in preclinical models; modulation of autophagy and cellular senescence in some models (evidence inconclusive); potential inhibitory activity on specific kinases and modulation of the cell cycle (relevant mainly in preclinical oncology); interactions with receptors and transporters (e.g., GABA-A in neurobiological contexts; inhibition of some enzymes/transporters involved in drug metabolism in vitro).
Scientific benefits
Contraindications
- Pregnancy and breastfeeding: insufficient data for the use of isolated apigenin; caution due to possible biological activity and interactions.
- Known allergy to plants containing apigenin (e.g., Asteraceae) or to components of the supplement.
- Significant liver or kidney disease: caution due to metabolism and elimination of conjugates and potential drug interactions.
- History of bleeding or anticoagulant/antiplatelet therapy: caution due to possible pharmacodynamic or pharmacokinetic interactions (evidence not definitive).
Side effects
- Gastrointestinal disturbances (nausea, dyspepsia, diarrhea) occasionally reported with high-dose polyphenols.
- Drowsiness or sedation in sensitive individuals (plausible due to neurobiological interactions; more often associated with chamomile/extracts).
- Headache or dizziness (uncommon, non-specific reports).
- Allergic reactions: possible especially in individuals allergic to plants of the Asteraceae family (e.g., chamomile), if exposure occurs through plant extracts.
Interactions
- Possible inhibition/alteration of cytochrome P450 enzymes and UGT in vitro (e.g., CYP3A4, CYP2C9, UGT): may theoretically modify levels of drugs metabolized through these pathways; clinical relevance depends on dose/formulation and the drug.
- Possible interaction with transporters (e.g., P-gp) described in experimental models: potential variation in the absorption of some drugs.
- Sedatives/anxiolytics: possible additive effect on drowsiness (especially if combined with other compounds active on the CNS).
- Anticoagulants/antiplatelets (e.g., warfarin, DOACs, aspirin, clopidogrel): caution due to potential increased risk of bleeding or alterations in plasma levels (mechanisms inconclusive).
- Drugs with a narrow therapeutic index metabolized by CYP/UGT (e.g., some immunosuppressants, antiarrhythmics): caution and need for professional evaluation.
Regulatory status
There is no regulatory recognition as a treatment for longevity or prevention of aging. In many countries it may be sold as a supplement ingredient or as a component of botanical extracts, with specific rules on claims and safety. The exact status depends on the jurisdiction.
Supplements and peptides
LongevityAstaxanthin
Astaxanthin is a carotenoid from the xanthophyll family (a red-orange pigment) produced mainly by microalgae (e.g.…
LongevityBerberine
Berberine is a plant alkaloid found in various plants (e.g. Berberis spp.) and traditionally used in the…
LongevityCurcumin
Curcumin is the main curcuminoid of turmeric (Curcuma longa). It is widely studied for anti-inflammatory and…